Pentahibe Complete achieved 100% organoid establishment from cryopreserved duodenum, ileum, and colon biopsies, significantly outperforming standard freezing medium with 10% DMSO. With increased organoid count, sustained growth and consistent post-thaw structural preservation, Pentahibe helps deliver the reproducibility and performance organoid workflows depend on.

High-value patient-derived tissue samples are often scarce and difficult to obtain. Pentahibe Complete is designed to preserve the integrity of biobanked tissues – from collection to culture – so that less is lost and more becomes viable organoid material.

Pentahibe Complete supports the transition toward more predictive, human-relevant research models by enabling reliable cryopreservation for organoid workflows. With growing regulatory and scientific focus on New Approach Methodologies (NAMs), including the FDA Modernization Act 2.0, the low-DMSO, cGMP-compliant formulation is designed to support scalable workflows from early discovery through translational research and biobanking.